RethinkPeptides
ArticlesTopicsResearch

The Real BPC-157 Story

3 articles in this topic.

The Real BPC-157 Story

BPC-157 and the Gut-Brain Axis

How a gastric peptide affects brain neurotransmitters: BPC-157's dopamine and serotonin modulation, anxiety and depression models, and gut-brain research.

13 min read|Mar 21, 2026
The Real BPC-157 Story

BPC-157 for IBD: What the Evidence Actually Shows

BPC-157 entered Phase II trials for ulcerative colitis but results were never published. Review of all IBD evidence from animal models to the ghost trial.

14 min read|Mar 21, 2026
The Real BPC-157 Story

BPC-157 Oral Administration: The Stability Data

BPC-157 survives 24+ hours in human gastric juice, unlike most peptides. What the gastric stability data shows about oral vs injectable routes and gaps.

14 min read|Mar 21, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.